济川药业: 湖北济川药业股份有限公司关于收到药品注册申请受理通知书的公告

Group 1 - The company has received a notice of acceptance for the registration application of "Children's Constipation Granules" from the National Medical Products Administration, marking the entry into the review stage for domestic production registration [1][2] - The product is derived from a patented formula by Dr. Chen Yonghui, aimed at treating pediatric constipation with specific efficacy in strengthening the spleen and stomach, and promoting digestion [1][2] - Currently, there are no similar registered products in China specifically for treating pediatric constipation, positioning this product as a potential first in its category following the release of new clinical guidelines in 2024 [2] Group 2 - The project has accumulated an investment of approximately 51.42 million yuan [2] - The acceptance of the registration application does not have a significant immediate impact on the company's current performance, but the sales post-launch may be subject to various market factors [2]